832
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma

, , , , & ORCID Icon
Article: 2232372 | Received 23 Apr 2023, Accepted 24 Jun 2023, Published online: 12 Jul 2023

References

  • Deng Y, Li H, Wang M, et al. Global burden of thyroid cancer from 1990 to 2017. JAMA Netw Open. 2020;3(6):1. doi: 10.1001/jamanetworkopen.2020.8759.
  • Hu Y, Yin H-Y, Liu G-B, et al. Hyperthyroidism secondary to disseminated differentiated thyroid cancer on 99mTcO4 scan. Chin Med J. 2019;132(19):2390–8. doi: 10.1097/CM9.0000000000000462.
  • Hu J, Yuan IJ, Mirshahidi S, et al. Thyroid carcinoma: phenotypic features, underlying biology and potential relevance for targeting therapy. IJMS. 2021;22(4):1950. doi: 10.3390/ijms22041950.
  • Seib CD, Sosa JA. Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinol Metab Clin North Am. 2019;48(1):23–35. doi: 10.1016/j.ecl.2018.10.002.
  • Pandeya N, McLeod D, Balasubramaniam K, et al. Increasing thyroid cancer incidence in Q ueensland, a ustralia 1982–2008–true increase or overdiagnosis? Clin Endocrinol. 2016;84(2):257–264. doi: 10.1111/cen.12724.
  • Asa SL. The current histologic classification of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48(1):1–22. doi: 10.1016/j.ecl.2018.10.001.
  • Schlumberger M, Leboulleux S. Current practice in patients with differentiated thyroid cancer. Nat Rev Endocrinol. 2021;17(3):176–188. doi: 10.1038/s41574-020-00448-z.
  • Jalisi S, Ainsworth T, LaValley M. Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis. J Thyroid Res. 2010;2010:1–4. doi: 10.4061/2010/325602.
  • LiVolsi VA. Papillary carcinoma tall cell variant (TCV): a review. Endocr Pathol. 2010;21(1):12–15. doi: 10.1007/s12022-010-9106-y.
  • Fugazzola L, Muzza M, Pogliaghi G, et al. Intratumoral genetic heterogeneity in papillary thyroid cancer: occurrence and clinical significance. Cancers. 2020;12(2):383. doi: 10.3390/cancers12020383.
  • Chmielik E, Rusinek D, Oczko-Wojciechowska M, et al. Heterogeneity of thyroid cancer. Pathobiology. 2018;85(1-2):117–129. doi: 10.1159/000486422.
  • Prete A, Borges de Souza P, Censi S, et al. Update on fundamental mechanisms of thyroid cancer. Front Endocrinol. 2020;11:102. doi: 10.3389/fendo.2020.00102.
  • Grani G, Fumarola A. Thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy. J Clin Endocrinol Metab. 2014;99(6):1970–1982. doi: 10.1210/jc.2014-1098.
  • Nguyen QT, Lee EJ, Huang MG, et al. Diagnosis and treatment of patients with thyroid cancer. Am Health Drug Benefits. 2015;8(1):30.
  • Haymart MR, Banerjee M, Reyes-Gastelum D, et al. Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer. J Clin Endocrinol Metab. 2019;104(3):785–792. doi: 10.1210/jc.2018-01933.
  • Jiang L, Xiang Y, Huang R, et al. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation 131iodine scintigraphy in children and young adults with differentiated thyroid carcinoma. Pediatr Radiol. 2021;51(9):1724–1731. doi: 10.1007/s00247-021-05039-2.
  • Xu F, Shao Z, Yang G, et al. The value of scintigraphy, computed tomography, magnetic resonance imaging, and single-photon emission computed tomography/computed tomography for the diagnosis of ectopic thyroid in the head and neck: a STROBE-compliant retrospective study. Medicine. 2018;97(13):e0239. doi: 10.1097/MD.0000000000010239.
  • Zahra HO, Omran GA, Gewely AG, et al. Prognostic value of serum thyroglobulin and anti-Thyroglobulin antibody in thyroid carcinoma patients following thyroidectomy. Diagnostics. 2021;11(11):2080. doi: 10.3390/diagnostics11112080.
  • Park S, Jeon MJ, Oh H-S, et al. Changes in serum thyroglobulin levels after lobectomy in patients with low-risk papillary thyroid cancer. Thyroid. 2018;28(8):997–1003. doi: 10.1089/thy.2018.0046.
  • Jo K, Lim D-J. Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer. Korean J Intern Med. 2018;33(6):1050–1057. doi: 10.3904/kjim.2018.289.
  • Zhao Z, Zhu L, Wang Z. Dynamic changes and clinical significance of thyroid auto-antibodies before and after radioiodine treatment for graves’ disease. Label Immunoassays Clin Med. 2005;12(1):24–26.
  • Sollini M, Cozzi L, Chiti A, et al. Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: where do we stand? Eur J Radiol. 2018;99:1–8. doi: 10.1016/j.ejrad.2017.12.004.
  • Algeciras-Schimnich A. Thyroglobulin measurement in the management of patients with differentiated thyroid cancer. Crit Rev Clin Lab Sci. 2018;55(3):205–218. doi: 10.1080/10408363.2018.1450830.
  • Matrone A, Latrofa F, Torregrossa L, et al. Changing trend of thyroglobulin antibodies in patients with differentiated thyroid cancer treated with total thyroidectomy without 131I ablation. Thyroid. 2018;28(7):871–879. doi: 10.1089/thy.2018.0080.
  • Kim H, Park SY, Choe J-H, et al. Preoperative serum thyroglobulin and its correlation with the burden and extent of differentiated thyroid cancer. Cancers. 2020;12(3):625. doi: 10.3390/cancers12030625.
  • Patell R, Mikhael A, Tabet M, et al. Assessing the utility of preoperative serum thyroglobulin in differentiated thyroid cancer: a retrospective cohort study. Endocrine. 2018;61(3):506–510. doi: 10.1007/s12020-018-1643-z.
  • Bayer MF, Kriss JP. Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab. 1979;49(4):557–564. doi: 10.1210/jcem-49-4-557.
  • Schneider AB, Pervos R. Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab. 1978;47(1):126–137. doi: 10.1210/jcem-47-1-126.
  • Reverter JL, Rosas-Allende I, Puig-Jove C, et al. Prognostic significance of thyroglobulin antibodies in differentiated thyroid cancer. J Thyroid Res. 2020;2020:1–6. doi: 10.1155/2020/8312628.
  • Ringel MD, Nabhan F. Approach to follow-up of the patient with differentiated thyroid cancer and positive anti-thyroglobulin antibodies. J Clin Endocrinol Metab. 2013;98(8):3104–3110. doi: 10.1210/jc.2013-1412.
  • Morgenthaler NG, Froehlich J, Rendl J, et al. Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin. Clin Chem. 2002;48(7):1077–1083. doi: 10.1093/clinchem/48.7.1077.
  • Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid: official Journal of the American Thyroid Association. 2003;13(1):3–126.
  • Batawil N. Papillary thyroid cancer with bilateral adrenal metastases. Thyroid. 2013;23(12):1651–1654. doi: 10.1089/thy.2013.0065.
  • Song X, Luo Z, Sun H, et al. Systematic review and meta-analysis of the diagnostic value of radionuclide ­imaging for thyroid nodules. Gland Surg. 2021;10(12):3351–3361. doi: 10.21037/gs-21-766.
  • Pusztaszeri M, Bongiovanni M. The impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) on the diagnosis of thyroid nodules. Gland Surg. 2019;8(Suppl 2):S86–S97. doi: 10.21037/gs.2018.12.01.
  • Zhao H-N, Liu J-Y, Lin Q-Z, et al. Partially cystic thyroid cancer on conventional and elastographic ultrasound: a retrospective study and a machine learning—assisted system. Ann Transl Med. 2020;8(7):495–495. doi: 10.21037/atm.2020.03.211.